• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. Alt-proteins: A promising future
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Dimethoxybenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Methoxybenzenes Dimethoxybenzenes

Introduction to N-Me-2C-H Hydrochloride (CAS No: 13063-01-9)

N-Me-2C-H Hydrochloride, chemically known by its CAS number 13063-01-9, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and a candidate for further pharmacological investigation.

The molecular structure of N-Me-2C-H Hydrochloride consists of a nitrogen-methylated derivative of a cyclohexane-based core, which is a common motif in many biologically active molecules. This structural framework suggests potential interactions with biological targets, such as enzymes and receptors, which are critical for drug efficacy. The presence of the hydrochloride moiety not only improves the compound's pharmacokinetic properties but also allows for easier formulation and administration in therapeutic settings.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to explore the binding affinity and interaction mechanisms of N-Me-2C-H Hydrochloride with various biological targets. Studies have indicated that this compound exhibits promising binding properties with certain enzymes involved in metabolic pathways, suggesting its potential as an inhibitor or modulator. These findings are particularly exciting as they could lead to the development of novel therapeutic agents targeting these metabolic pathways.

In addition to its structural significance, N-Me-2C-H Hydrochloride has been investigated for its role in synthetic chemistry. Its cyclohexane-based core provides a versatile platform for further functionalization, allowing chemists to design derivatives with tailored biological activities. This flexibility has made it a valuable starting material for the synthesis of more complex molecules, which could have applications in both academic research and industrial drug development.

The hydrochloride salt form of this compound also offers advantages in terms of storage and handling. Its enhanced stability under various conditions makes it easier to maintain throughout the research and development process. This stability is crucial for ensuring consistent quality and performance, which are essential factors in pharmaceutical applications.

Current research is focusing on exploring the pharmacological potential of N-Me-2C-H Hydrochloride. Preliminary studies have shown that it may have inhibitory effects on certain enzymes associated with inflammation and pain pathways. These findings are particularly relevant given the increasing demand for alternative treatments for chronic inflammatory conditions. Further investigation is needed to fully understand its mechanism of action and potential therapeutic applications.

The synthesis of N-Me-2C-H Hydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advances in synthetic methodologies have made it possible to produce this compound more efficiently, reducing costs and environmental impact. These improvements are essential for scaling up production for both research and commercial purposes.

The solubility profile of N-Me-2C-H Hydrochloride is another area of interest. Its ability to dissolve in both water and organic solvents makes it a versatile compound that can be formulated into various dosage forms. This property is particularly advantageous for developing oral medications, injectables, and topical formulations, broadening its potential applications in therapeutic settings.

In conclusion, N-Me-2C-H Hydrochloride (CAS No: 13063-01-9) is a compound with significant potential in pharmaceutical research and development. Its unique structural features, combined with its favorable physicochemical properties, make it a valuable asset in both academic laboratories and industrial settings. As research continues to uncover new applications and therapeutic benefits, this compound is poised to play a crucial role in the development of next-generation pharmaceuticals.

• 94724-12-6(Benzeneethanamine,4-methoxy-3,5-bis[[2-methoxy-5-[2-(methylamino)ethyl]phenyl]methyl]-N-methyl-)
• 3166-74-3(2,5-Dimethoxyphenethylamine hydrochloride)
• 104338-26-3([2-(2-methoxyphenyl)ethyl](methyl)amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)